Japanese Study Finds Sulfur Compound Boosts Muscle Repair Signal

Key points

• A team led by Professor Ryuichi Tatsumi at Kyushu University identified that LASSS increases the binding affinity of hepatocyte growth factor (HGF) to the c-met receptor by more than twofold.
• The study suggests that aging weakens muscle repair because HGF undergoes nitration, a chemical change that prevents it from activating satellite cells responsible for regeneration.
• While both LASSS and glutathione trisulfide (GSSSG) reduced nitration in lab tests, only LASSS significantly improved receptor binding, creating what researchers call 'Super HGF'.
• Mouse experiments using a tail-suspension model showed that LASSS reduced HGF nitration in living tissue, though it did not restore lost muscle mass or strength in these trials.
• The findings were published in Scientific Reports, highlighting a potential new strategy to protect existing biological repair mechanisms rather than replacing them.

Background

This research adds to a growing body of evidence regarding age-related muscle decline, or sarcopenia. Recent studies, including one from Simon Fraser University, indicate that anabolic resistance is a multifactorial issue involving impaired protein synthesis, suggesting that single-target therapies may be insufficient. Meanwhile, other research highlights that muscle loss in older adults is not uniform, with legs often experiencing greater deficits than arms. These findings underscore the complexity of maintaining muscle function as the body ages, where both cellular signaling and physical distribution of muscle mass play critical roles.

How outlets are covering it

ScienceDaily and UA.NEWS both report on the Kyushu University findings, emphasizing the potential of LASSS to enhance HGF activity. However, both outlets stress that while the compound improves molecular binding, it has not yet been proven to restore muscle strength in vivo. MindBodyGreen offers a different angle, focusing on the uneven distribution of muscle loss in sarcopenia, suggesting that lower-body strength requires specific attention. In contrast, a Simon Fraser University study argues that sarcopenia is driven by multiple factors, including anabolic resistance, implying that targeting a single molecular pathway like HGF may not be a comprehensive solution. While the Japanese study focuses on protecting a specific repair signal, the SFU research suggests that effective treatments must address broader systemic issues in muscle protein synthesis.

Why it matters

Understanding how to protect the body's natural muscle repair mechanisms could lead to new interventions for age-related mobility issues. If LASSS can effectively enhance HGF activity in humans, it may help maintain independence and reduce fall risks in older adults. However, the current evidence is limited to laboratory and animal models, and further studies are needed to confirm safety and efficacy in aging populations.

What to watch

Researchers must conduct studies in aging animals to determine if LASSS can safely and effectively preserve muscle function. Future trials will need to assess whether the enhanced binding of HGF translates into improved muscle regeneration and strength in living organisms, moving beyond the current evidence of reduced nitration.